Luke Nathaniel Walker - 03 Oct 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Oct 2022
Net transactions value
$0
Form type
4
Filing time
04 Oct 2022, 16:12:53 UTC
Next filing
26 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Award $0 +305,000 $0.000000 305,000 03 Oct 2022 Common Stock 305,000 $1.08 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was granted pursuant to the Issuer's 2022 Inducement Plan.
F2 1/4th of the total stock option will vest and become exercisable on the first anniversary of the vesting commencement date of October 3, 2022 ("VCD"), and 1/36th of the remaining stock option will vest and become exercisable monthly on the same day of each month following the VCD, subject to the continued service of the Reporting Person on each vesting date.